Skip to main content

Advertisement

SpringerLink
Log in

Imiquimod-induced widespread psoriasi-form eruptions

  • Correspondence
  • Published:
European Journal of Dermatology

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gilliet M, Conrad C, Geiges M, et al. Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol 2004;140:1490–5.

    Article  CAS  PubMed  Google Scholar 

  2. Wu JK, Siller G, Strutton G. Psoriasis induced by topical imiquimod. Australas J Dermatol 2004;45:47–50.

    Article  PubMed  Google Scholar 

  3. Rajan N, Langtry JA. Generalized exacerbation of psoriasis associated with imiquimod cream treatment of superficial basal cell carcinomas. Clin Exp Dermatol 2006;31:140–1.

    Article  CAS  PubMed  Google Scholar 

  4. Fanti PA, Dika E, Vaccari S, et al. Generalized psoriasis induced by topical treatment of actinic keratosis with imiquimod. Int J Dermatol 2006; 45:1464–5.

    Article  CAS  PubMed  Google Scholar 

  5. Patel U, Mark NM, Machler BC, Levine VJ. Imiquimod 5% cream induced psoriasis: a case report, summary of the literature and mechanism. Br J Dermatol 2011;164:670–2.

    CAS  PubMed  Google Scholar 

  6. Smith WA, Siegel D, Lyon VB, Holland KE. Psoriasiform eruption and oral ulcerations as adverse effects of topical 5% imiquimod treatment in children: a report of four cases. Pediatr Dermatol 2013;30:e157–60.

    Article  PubMed  Google Scholar 

  7. Tsutsumi R, Yoshida Y, Yamamoto O. Imiquimod-induced pso-riatic erythroderma treated with infliximab. Acta Derm Venereol 2017;97:279–80.

    Article  PubMed  Google Scholar 

  8. Oyama S, Funasaka Y, Tsuchiya S-I, Kawana S, Saeki H. Increased number of mast cells in the dermis in actinic keratosis lesions effectively treated with imiquimod. J Dermatol 2017;44:944–9.

    Article  CAS  PubMed  Google Scholar 

  9. Zhang L, Liu D, Pu D, et al. The TLR7 agonist imiquimod promote the immunogenicity of mesenchymal stem cells. Biol Res 2015;48:6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Tortola L, Rosenwald E, Abel B, et al. Psoriasiform dermatitis is driven by IL-36-mediated DC-keratinocyte crosstalk. J Clin Invest 2012;122:3965–76.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Fukushima Medical University, Fukushima, Japan

    Shohei Igari, Mikio Ohtsuka & Toshiyuki Yamamoto

Authors
  1. Shohei Igari
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mikio Ohtsuka
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Toshiyuki Yamamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shohei Igari.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Igari, S., Ohtsuka, M. & Yamamoto, T. Imiquimod-induced widespread psoriasi-form eruptions. Eur J Dermatol 29, 225–227 (2019). https://doi.org/10.1684/ejd.2019.3517

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1684/ejd.2019.3517

Search

Navigation